74 related articles for article (PubMed ID: 11917575)
21. Preliminary assessment of the AutoCyte PREP. Direct-to-vial performance.
Tench W
J Reprod Med; 2000 Nov; 45(11):912-6. PubMed ID: 11127103
[TBL] [Abstract][Full Text] [Related]
22. Accuracy of a slide profiler for endocervical cell detection in no-further-review conventional Pap smears.
Rowe LR; Marshall CJ; Berry M; Larson MA; Bentz JS
Acta Cytol; 2003; 47(4):602-4. PubMed ID: 12920753
[TBL] [Abstract][Full Text] [Related]
23. [The use of a computerised system in the reading of cytological cervicovaginals smears during programming of regional screening (one year of experience using the autopap system)].
Orlassino R; Fabbrini T; Gallo C; Vineis C
Pathologica; 2005 Apr; 97(2):78-83. PubMed ID: 16032952
[TBL] [Abstract][Full Text] [Related]
24. The primary screening clinical trials of the TriPath AutoPap System.
Wilbur DC; Norton MK
Epidemiology; 2002 May; 13 Suppl 3():S30-3. PubMed ID: 12071481
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of the FocalPoint GS system performance in an Italian population-based screening of cervical abnormalities.
Passamonti B; Bulletti S; Camilli M; D'Amico MR; Di Dato E; Gustinucci D; Martinelli N; Malaspina M; Spita N
Acta Cytol; 2007; 51(6):865-71. PubMed ID: 18077978
[TBL] [Abstract][Full Text] [Related]
26. AutoCyte SCREEN interactive automated primary cytology screening system. A preliminary evaluation.
Takahashi M; Kimura M; Akagi A; Naitoh M
Acta Cytol; 1998; 42(1):185-8. PubMed ID: 9479338
[TBL] [Abstract][Full Text] [Related]
27. Endometrial cells and the AutoPap System for primary screening of cervicovaginal Pap smears.
Walts AE; Thomas P
Diagn Cytopathol; 2002 Oct; 27(4):232-7. PubMed ID: 12357502
[TBL] [Abstract][Full Text] [Related]
28. Results of AutoPap system-assisted and manual cytologic screening. A comparison.
Wertlake P
J Reprod Med; 1999 Jan; 44(1):11-7. PubMed ID: 9987733
[TBL] [Abstract][Full Text] [Related]
29. Usefulness of liquid-based cytology specimens for the immunocytochemical study of p16 expression and human papillomavirus testing: a comparative study using simultaneously sampled histology materials.
Yoshida T; Fukuda T; Sano T; Kanuma T; Owada N; Nakajima T
Cancer; 2004 Apr; 102(2):100-8. PubMed ID: 15098254
[TBL] [Abstract][Full Text] [Related]
30. Effectiveness of AutoPap system location-guided screening in the evaluation of cervical cytology smears.
Stevens MW; Milne AJ; Parkinson IH; Nespolon WW; Fazzalari NL; Arora N; Dodd TJ
Diagn Cytopathol; 2004 Aug; 31(2):94-9. PubMed ID: 15282720
[TBL] [Abstract][Full Text] [Related]
31. Gain of the 3q26 region in cervicovaginal liquid-based pap preparations is associated with squamous intraepithelial lesions and squamous cell carcinoma.
Caraway NP; Khanna A; Dawlett M; Guo M; Guo N; Lin E; Katz RL
Gynecol Oncol; 2008 Jul; 110(1):37-42. PubMed ID: 18433848
[TBL] [Abstract][Full Text] [Related]
32. Use of a liquid-based, thin-layer Pap test in a community hospital. Impact on cytology performance and productivity.
Sass MA
Acta Cytol; 2004; 48(1):17-22. PubMed ID: 14969176
[TBL] [Abstract][Full Text] [Related]
33. Is there a role for the thinprep imaging system in reporting anal cytology?
Margaret Roberts J; Jin F; Ekman D; Kay Adams M; Lindsay McDonald R; Kathleen Thurloe J; Richards A; Mary Poynten I; Law C; Kincaid Fairley C; John Hillman R; Tabrizi SN; Marie Cornall A; James Templeton D; Marie Garland S; Edwin Grulich A; Farnsworth A
Diagn Cytopathol; 2016 May; 44(5):384-8. PubMed ID: 26876374
[TBL] [Abstract][Full Text] [Related]
34. Assisted primary screening using the automated ThinPrep Imaging System.
Biscotti CV; Dawson AE; Dziura B; Galup L; Darragh T; Rahemtulla A; Wills-Frank L
Am J Clin Pathol; 2005 Feb; 123(2):281-7. PubMed ID: 15842055
[TBL] [Abstract][Full Text] [Related]
35. The Becton Dickinson FocalPoint GS Imaging System: clinical trials demonstrate significantly improved sensitivity for the detection of important cervical lesions.
Wilbur DC; Black-Schaffer WS; Luff RD; Abraham KP; Kemper C; Molina JT; Tench WD
Am J Clin Pathol; 2009 Nov; 132(5):767-75. PubMed ID: 19846820
[TBL] [Abstract][Full Text] [Related]
36. Comparison of TriPath thin-layer technology with conventional methods on nongynecologic specimens.
Nicol TL; Kelly D; Reynolds L; Rosenthal DL
Acta Cytol; 2000; 44(4):567-75. PubMed ID: 10934950
[TBL] [Abstract][Full Text] [Related]
37. Impact of the AutoPap (currently Focalpoint) primary screening system location guide use on interpretation time and diagnosis.
Ronco G; Vineis C; Montanari G; Orlassino R; Parisio F; Arnaud S; Berardengo E; Fabbrini T; Segnan N
Cancer; 2003 Apr; 99(2):83-8. PubMed ID: 12704687
[TBL] [Abstract][Full Text] [Related]
38. Cervical specimens collected in liquid buffer are suitable for both cytologic screening and ancillary human papillomavirus testing.
Sherman ME; Schiffman MH; Lorincz AT; Herrero R; Hutchinson ML; Bratti C; Zahniser D; Morales J; Hildesheim A; Helgesen K; Kelly D; Alfaro M; Mena F; Balmaceda I; Mango L; Greenberg M
Cancer; 1997 Apr; 81(2):89-97. PubMed ID: 9126136
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of the CytoRich slide preparation process.
Laverty CR; Farnsworth A; Thurloe JK; Grieves A; Bowditch R
Anal Quant Cytol Histol; 1997 Jun; 19(3):239-45. PubMed ID: 9196807
[TBL] [Abstract][Full Text] [Related]
40. Quality control of the autopap screening system employed as a primary screening device: rapid review of smears coded as no further review.
Bulgaresi P; Cariaggi MP; Troni GM; Ciatto S
Tumori; 2006; 92(4):276-8. PubMed ID: 17036515
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
